Register to receive a free European Market Report Suite for Anesthesia, Respiratory and Sleep Management report synopsis and brochure

MedInvent, LLC, recently announced CE Marking of its patented intranasal delivery device, the NasoNeb II Nasal Nebulizer, manufactured, marketed and sold in the United States since 2009. MedInvent is also pleased to announce its first EU distribution contract with Vedise Hospital in Rome, to market the NasoNeb System in Italy, San Marino and Vatican City. Vedise Hospital has marketed ENT products for over 20 years, serving Otolaryngologists in Italy.

In addition, MedInvent has obtained ISO 13485 and CMDCAS certification. These certifications, together with CE Marking, enable MedInvent to expand the market for the NasoNeb II Nasal Nebulizer to the member countries of the European Union and to seek regulatory approval in countries around the world.

The NasoNeb System has been the delivery device of choice in multiple peer-reviewed trials, where it has demonstrated positive outcomes in chronic sinusitis and allergic rhinitis patients. The System is a controlled intranasal delivery system whereby its unique combination of droplet size, airflow, and fluid volume allows delivery solely to the nasal and paranasal sinus cavities. In addition, the NasoNeb offers broad intranasal drug deposition, high intranasal drug retention, and no pulmonary deposition. Other delivery devices reach a limited area of the nasal cavity, deliver a weak solution, or deliver a portion of the medication to the lungs, which can cause unwanted side effects.

“We look forward to working with European physicians treating patients who suffer with sinus conditions,” said William Flickinger, MedInvent Managing Partner. “In particular, for those people who have not responded to therapy in the way their physicians would have expected, despite their physician’s best efforts, the NasoNeb System represents a promising new delivery method to ensure that a high concentration of medication is delivered throughout the nasal and paranasal sinus cavities.”

In the US, the NasoNeb System is available through the member pharmacies of the NasoNeb Pharmacy Network. Distributor inquiries are welcome.

About MedInvent, LLC
MedInvent, LLC, is a privately-held limited liability corporation with operations in Cleveland, OH. MedInvent develops and markets the NasoNeb Family of drug delivery systems for the topical delivery of medication to the nasal and paranasal sinus cavities. MedInvent is a non-diluted company seeking to raise its series A round to fund European Union launch, complete development of next generation products, and undertake clinical trials.

For more information, please visit the MedInvent, website at

For Further Information
More on the anesthesia monitoring market in Europe can be found in a series of reports published by iData Research entitled the European Market Report Suite for Anesthesia, Respiratory and Sleep Management. The suite covers reports on the following markets: Anesthesia Delivery Units, Anesthesia Disposables, Ventilators, Nebulizers, Respiratory Disposables, Oxygen Therapy, Sleep Apnea Devices and Interfaces, and Sleep Diagnostic Devices.

The iData report series on anesthesia, respiratory and sleep management covers the U.S. and 15 countries in Europe including Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, the United Kingdom and Switzerland. Reports provide a comprehensive analysis including units sold, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about anesthesia, respiratory and sleep management market data or procedure data, register online or email us at [email protected] for a European Market Report Suite for Anesthesia, Respiratory and Sleep Management brochure and synopsis.

About iData Research
iData Research is an international market research and consulting firm, dedicated to providing the best in business intelligence for the medical device industry. Our research empowers our clients by providing them with the necessary tools to achieve their goals and do it right the first time. iData covers research in: Laparoscopy, Urology, Gynecology, Endoscopy, Dental Operatory Equipment, Dental Material, Dental Lasers, Dental Prosthetics, Dental CAD/CAM, Dental Bone Graft Substitutes, Ophthalmics, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Vascular Access, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics and more.

We have built a reputation and earned our clients’ trust based on consistent and uniquely intelligent research that allows our customers to make confident decisions and impact their businesses. A combination of market expertise and over a decade of experience has resulted in a deep understanding of the medical device industry that has inspired innovation and propelled our clients to success.

About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.

About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.

Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook:
Follow us on LinkedIn:
Follow us on Twitter: